2024-10-30 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**Company Overview:** UnitedHealth Group Inc. is a leading provider of health care products and services in the United States. 

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative Return (UNH):** 283.94%
* **Cumulative Return (VOO):** 136.74%
* **Difference:** 147.2%
* **Relative Divergence:** 59.7% 

This indicates that UNH has significantly outperformed the S&P 500 over the historical period, currently sitting at the 59.7th percentile of its historical divergence range. 

**2. Recent Price Movement:**

* **Closing Price:** $562.13
* **5-Day Moving Average:** $563.48
* **20-Day Moving Average:** $577.79
* **60-Day Moving Average:** $580.79

The stock is currently trading below its 5-, 20-, and 60-day moving averages, indicating a short-term downtrend. 

**3. Technical Indicators:**

* **RSI:** 36.44 
* **PPO:** -0.32
* **Delta_Previous_Relative_Divergence:** -8.03 
* **Expected Return:** 53.56%

The RSI suggests that UNH is in oversold territory, but the PPO and Relative Divergence indicate a recent decline in momentum. The Expected Return highlights the potential for long-term outperformance compared to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-09 | 4.58 | $98.86B |
| 2024-05-09 | -1.53 | $99.80B |
| 2023-11-06 | 6.31 | $92.36B |
| 2023-08-02 | 5.89 | $92.90B |
| 2024-08-09 | 5.89 | $92.90B |

The company reported strong revenue growth in recent quarters, but EPS has been volatile. The most recent earnings report (2024-08-09) was slightly below analysts' expectations. 

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-06-30 | $97.86B | 21.52% |
| 2024-03-31 | $98.78B | 22.26% |
| 2023-12-31 | $93.25B | 22.33% |
| 2023-09-30 | $91.36B | 24.51% |
| 2023-06-30 | $91.79B | 23.72% |

UNH has consistently generated strong revenue growth and maintained a healthy profit margin, demonstrating its ability to manage costs effectively.

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-06-30 | $89.36B | 4.72% |
| 2024-03-31 | $86.69B | -1.63% |
| 2023-12-31 | $88.76B | 6.15% |
| 2023-09-30 | $84.49B | 6.91% |
| 2023-06-30 | $82.35B | 6.65% |

Equity has grown steadily, and ROE remains positive, indicating the company's strong financial position.

**6. News and Recent Issues:**

* **Recent Earnings Release:**  The most recent earnings call on August 9th, 2024, highlighted the company's strong revenue growth and its ongoing commitment to innovation in the healthcare industry. 
* **Market Outlook:** FINBOLD recently published an article titled "UnitedHealth Group (UNH): A Healthcare Giant on a Growth Trajectory". The article praised the company's strong financial position, its market dominance, and its commitment to providing affordable and accessible healthcare solutions. 
* **Analyst Opinions:** Most analysts remain bullish on UNH, with many citing the company's strong earnings potential and its strategic positioning within the healthcare industry.

**7. Overall Analysis:**

UNH is a solid company with a history of strong performance and a bright future in the healthcare industry. The stock is currently trading below its moving averages, but technical indicators suggest a potential oversold condition. The company's recent earnings performance and its long-term growth prospects justify continued investment.

**8. Recommendation:**

Based on the available information, UNH appears to be a strong investment opportunity. Its track record of outperforming the S&P 500, coupled with strong financial performance and a positive market outlook, makes it a compelling addition to any diversified portfolio. Consider holding UNH for the long term, as its potential for continued growth remains high. 
